Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in J Magn Reson Imaging

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    May 2018
  1. SHIRADKAR R, Ghose S, Jambor I, Taimen P, et al
    Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    J Magn Reson Imaging. 2018 May 7. doi: 10.1002/jmri.26178.
    PubMed     Text format     Abstract available


    April 2018
  2. SONG Y, Zhang YD, Yan X, Liu H, et al
    Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.
    J Magn Reson Imaging. 2018 Apr 16. doi: 10.1002/jmri.26047.
    PubMed     Text format     Abstract available


    March 2018
  3. GAUR S, Harmon S, Mehralivand S, Bednarova S, et al
    Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
    J Magn Reson Imaging. 2018 Mar 31. doi: 10.1002/jmri.26025.
    PubMed     Text format     Abstract available


  4. LUZURIER A, Jouve De Guibert PH, Allera A, Feldman SF, et al
    Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    J Magn Reson Imaging. 2018 Mar 8. doi: 10.1002/jmri.25991.
    PubMed     Text format     Abstract available


    February 2018
  5. ALGOHARY A, Viswanath S, Shiradkar R, Ghose S, et al
    Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
    J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983.
    PubMed     Text format     Abstract available


  6. WANG J, Wu CJ, Bao ML, Zhang J, et al
    Using support vector machine analysis to assess PartinMR: A new prediction model for organ-confined prostate cancer.
    J Magn Reson Imaging. 2018 Feb 13. doi: 10.1002/jmri.25961.
    PubMed     Text format     Abstract available


  7. LIU W, Liu XH, Tang W, Gao HB, et al
    Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.
    J Magn Reson Imaging. 2018 Feb 7. doi: 10.1002/jmri.25958.
    PubMed     Text format     Abstract available


    November 2017
  8. GIGANTI F, Gambarota G, Moore CM, Robertson NL, et al
    Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
    J Magn Reson Imaging. 2017 Nov 14. doi: 10.1002/jmri.25891.
    PubMed     Text format     Abstract available


    September 2017
  9. YIM JH, Kim CK, Kim JH
    Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    J Magn Reson Imaging. 2017 Sep 13. doi: 10.1002/jmri.25856.
    PubMed     Text format     Abstract available


  10. DWIVEDI DK, Kumar R, Dwivedi AK, Bora GS, et al
    Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
    J Magn Reson Imaging. 2017 Sep 4. doi: 10.1002/jmri.25850.
    PubMed     Text format     Abstract available


    June 2017
  11. HEIDKAMP J, Hoogenboom M, Kovacs IE, Veltien A, et al
    Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.
    J Magn Reson Imaging. 2017 Jun 5. doi: 10.1002/jmri.25785.
    PubMed     Text format     Abstract available


    April 2017
  12. KRISHNA S, Lim CS, McInnes MD, Flood TA, et al
    Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    J Magn Reson Imaging. 2017 Apr 7. doi: 10.1002/jmri.25729.
    PubMed     Text format     Abstract available


    March 2017
  13. STRAUB S, Laun FB, Emmerich J, Jobke B, et al
    Potential of quantitative susceptibility mapping for detection of prostatic calcifications.
    J Magn Reson Imaging. 2017;45:889-898.
    PubMed     Text format     Abstract available


    February 2017
  14. LIN YC, Lin G, Hong JH, Lin YP, et al
    Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology.
    J Magn Reson Imaging. 2017 Feb 8. doi: 10.1002/jmri.25583.
    PubMed     Text format     Abstract available


  15. JAMBOR I, Bostrom PJ, Taimen P, Syvanen K, et al
    Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial).
    J Magn Reson Imaging. 2017 Feb 6. doi: 10.1002/jmri.25641.
    PubMed     Text format     Abstract available


  16. WASEDA Y, Yoshida S, Takahara T, Kwee TC, et al
    Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    J Magn Reson Imaging. 2017 Feb 2. doi: 10.1002/jmri.25593.
    PubMed     Text format     Abstract available


  17. WOLF MB, Edler C, Tichy D, Rothke MC, et al
    Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    J Magn Reson Imaging. 2017 Feb 2. doi: 10.1002/jmri.25635.
    PubMed     Text format     Abstract available


    January 2017
  18. SABOURI S, Fazli L, Chang SD, Savdie R, et al
    MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology.
    J Magn Reson Imaging. 2017 Jan 27. doi: 10.1002/jmri.25624.
    PubMed     Text format     Abstract available


  19. HECTORS SJ, Besa C, Wagner M, Jajamovich GH, et al
    DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    J Magn Reson Imaging. 2017 Jan 16. doi: 10.1002/jmri.25631.
    PubMed     Text format     Abstract available


    December 2016
  20. GINSBURG SB, Algohary A, Pahwa S, Gulani V, et al
    Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    J Magn Reson Imaging. 2016 Dec 19. doi: 10.1002/jmri.25562.
    PubMed     Text format     Abstract available


    November 2016
  21. LIM CS, McInnes MD, Lim RS, Breau RH, et al
    Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.
    J Magn Reson Imaging. 2016 Nov 3. doi: 10.1002/jmri.25539.
    PubMed     Text format     Abstract available


    October 2016
  22. PARK JJ, Park BK
    Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS.
    J Magn Reson Imaging. 2016 Oct 26. doi: 10.1002/jmri.25534.
    PubMed     Text format     Abstract available


  23. KIM W, Kim CK, Park JJ, Kim M, et al
    Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI.
    J Magn Reson Imaging. 2016 Oct 17. doi: 10.1002/jmri.25515.
    PubMed     Text format     Abstract available


  24. SCHIEDA N, Lim CS, Idris M, Lim RS, et al
    MRI assessment of pathological stage and surgical margins in anterior prostate cancer (APC) using subjective and quantitative analysis.
    J Magn Reson Imaging. 2016 Oct 11. doi: 10.1002/jmri.25510.
    PubMed     Text format     Abstract available


  25. GORDON LG, James R, Tuffaha HW, Lowe A, et al
    Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.
    J Magn Reson Imaging. 2016 Oct 11. doi: 10.1002/jmri.25504.
    PubMed     Text format     Abstract available


    September 2016
  26. ZHANG YD, Wu CJ, Bao ML, Li H, et al
    MR-based prognostic nomogram for prostate cancer after radical prostatectomy.
    J Magn Reson Imaging. 2016 Sep 21. doi: 10.1002/jmri.25441.
    PubMed     Text format     Abstract available


  27. REAM JM, Doshi AM, Dunst D, Parikh N, et al
    Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.
    J Magn Reson Imaging. 2016 Sep 20. doi: 10.1002/jmri.25451.
    PubMed     Text format     Abstract available


  28. LEE MS, Cho JY, Kim SY, Cheon GJ, et al
    Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
    J Magn Reson Imaging. 2016 Sep 1. doi: 10.1002/jmri.25384.
    PubMed     Text format     Abstract available


    August 2016
  29. WEIS J, von Below C, Tolf A, Ortiz-Nieto F, et al
    Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    J Magn Reson Imaging. 2016 Aug 24. doi: 10.1002/jmri.25443.
    PubMed     Text format     Abstract available


  30. BRUNSING RL, Schenker-Ahmed NM, White NS, Parsons JK, et al
    Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.
    J Magn Reson Imaging. 2016 Aug 16. doi: 10.1002/jmri.25419.
    PubMed     Text format     Abstract available


    July 2016
  31. YUAN Q, Costa DN, Senegas J, Xi Y, et al
    Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    J Magn Reson Imaging. 2016 Jul 21. doi: 10.1002/jmri.25391.
    PubMed     Text format     Abstract available


  32. SALAMI SS, Ben-Levi E, Yaskiv O, Turkbey B, et al
    Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
    J Magn Reson Imaging. 2016 Jul 13. doi: 10.1002/jmri.25363.
    PubMed     Text format     Abstract available


  33. GREER MD, Brown AM, Shih JH, Summers RM, et al
    Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
    J Magn Reson Imaging. 2016 Jul 8. doi: 10.1002/jmri.25372.
    PubMed     Text format     Abstract available


  34. AGARWAL HK, Mertan FV, Sankineni S, Bernardo M, et al
    Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    J Magn Reson Imaging. 2016 Jul 7. doi: 10.1002/jmri.25353.
    PubMed     Text format     Abstract available


    June 2016
  35. GNEP K, Fargeas A, Gutierrez-Carvajal RE, Commandeur F, et al
    Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer.
    J Magn Reson Imaging. 2016 Jun 27. doi: 10.1002/jmri.25335.
    PubMed     Text format     Abstract available


  36. GINSBURG SB, Taimen P, Merisaari H, Vainio P, et al
    Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    J Magn Reson Imaging. 2016 Jun 10. doi: 10.1002/jmri.25330.
    PubMed     Text format     Abstract available


    April 2016
  37. BALDISSEROTTO M, Neto EJ, Carvalhal G, de Toledo AF, et al
    Validation of PI-RADS v.2 for prostate cancer diagnosis with MRI at 3T using an external phased-array coil.
    J Magn Reson Imaging. 2016 Apr 26. doi: 10.1002/jmri.25284.
    PubMed     Text format     Abstract available


  38. ROSENKRANTZ AB, Shanbhogue AK, Wang A, Kong MX, et al
    Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.
    J Magn Reson Imaging. 2016;43:990-7.
    PubMed     Text format     Abstract available


    March 2016
  39. LIM C, Flood TA, Hakim SW, Shabana WM, et al
    Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    J Magn Reson Imaging. 2016;43:726-36.
    PubMed     Text format     Abstract available


    February 2016
  40. DE PERROT T, Scheffler M, Boto J, Delattre BM, et al
    Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    J Magn Reson Imaging. 2016 Feb 23. doi: 10.1002/jmri.25206.
    PubMed     Text format     Abstract available


  41. TAMADA T, Sone T, Kanomata N, Miyaji Y, et al
    Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.
    J Magn Reson Imaging. 2016 Feb 13. doi: 10.1002/jmri.25185.
    PubMed     Text format     Abstract available


  42. ROSENKRANTZ AB, Meng X, Ream JM, Babb JS, et al
    Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.
    J Magn Reson Imaging. 2016;43:325-32.
    PubMed     Text format     Abstract available


    November 2015
  43. REISCHAUER C, Koh DM, Froehlich JM, Patzwahl R, et al
    Pilot study on the detection of antiandrogen resistance using serial diffusion-weighted imaging of bone metastases in prostate cancer.
    J Magn Reson Imaging. 2015 Nov 20. doi: 10.1002/jmri.25102.
    PubMed     Text format     Abstract available


    July 2015
  44. TILAK G, Tuncali K, Song SE, Tokuda J, et al
    3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates.
    J Magn Reson Imaging. 2015;42:63-71.
    PubMed     Text format     Abstract available


  45. CEPEK J, Lindner U, Ghai S, Louis AS, et al
    Mechatronic system for in-bore MRI-guided insertion of needles to the prostate: An in vivo needle guidance accuracy study.
    J Magn Reson Imaging. 2015;42:48-55.
    PubMed     Text format     Abstract available


    June 2015
  46. COFFEY N, Schieda N, Cron G, Gulavita P, et al
    Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma.
    J Magn Reson Imaging. 2015;41:1639-45.
    PubMed     Text format     Abstract available


    April 2015
  47. ZHANG Z, Yuan Q, Zhou H, Zhao D, et al
    Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model.
    J Magn Reson Imaging. 2015 Apr 10. doi: 10.1002/jmri.24914.
    PubMed     Text format     Abstract available


    June 2014
  48. JAMBOR I, Kahkonen E, Taimen P, Merisaari H, et al
    Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
    J Magn Reson Imaging. 2014 Jun 23. doi: 10.1002/jmri.24682.
    PubMed     Text format     Abstract available


  49. GINSBURG SB, Viswanath SE, Bloch BN, Rofsky NM, et al
    Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.
    J Magn Reson Imaging. 2014 Jun 18. doi: 10.1002/jmri.24676.
    PubMed     Text format     Abstract available


    May 2014
  50. ROSENKRANTZ AB, Geppert C, Grimm R, Block TK, et al
    Dynamic contrast-enhanced MRI of the prostate with high spatiotemporal resolution using compressed sensing, parallel imaging, and continuous golden-angle radial sampling: Preliminary experience.
    J Magn Reson Imaging. 2014 May 16. doi: 10.1002/jmri.24661.
    PubMed     Text format     Abstract available


    April 2014
  51. KALAVAGUNTA C, Zhou X, Schmechel SC, Metzger GJ, et al
    Registration of in vivo prostate MRI and pseudo-whole mount histology using Local Affine Transformations guided by Internal Structures (LATIS).
    J Magn Reson Imaging. 2014 Apr 4. doi: 10.1002/jmri.24629.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: